ADC Therapeutics SA宣布,其备受关注的Lotis-5三期临床试验的顶线数据预计将在2026年第二季度获得。此外,公司计划在2026年年底前公布Lotis-5研究的完整数据集,以及Lotis-7试验的相关数据。
ADC Therapeutics SA宣布,其备受关注的Lotis-5三期临床试验的顶线数据预计将在2026年第二季度获得。此外,公司计划在2026年年底前公布Lotis-5研究的完整数据集,以及Lotis-7试验的相关数据。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.